BRIEF published on 11/24/2025 at 07:05, 10 days 22 hours ago Julius Baer Reports Record Assets and Strategic Refocus Global Expansion Assets Under Management Julius Baer Strategic Refocus Credit Review
PRESS RELEASE published on 11/24/2025 at 07:00, 10 days 22 hours ago Interim Management Statement for the first ten months of 2025 and conclusion of the credit review* Julius Baer Group Ltd. delivers improved performance with record assets under management, completed credit review, strengthens capital position, and announces new appointments New Appointments Assets Under Management Julius Baer Capital Position Credit Review
BRIEF published on 11/24/2025 at 06:35, 10 days 23 hours ago Victoria McLean Joins Julius Baer as Chief Compliance Officer Wealth Management Executive Board Julius Baer Compliance Officer Victoria McLean
PRESS RELEASE published on 11/24/2025 at 06:30, 10 days 23 hours ago Victoria McLean to become Chief Compliance Officer of Julius Baer and join the Executive Board Julius Baer appoints Victoria McLean as Chief Compliance Officer & Executive Board member. McLean brings 30 years of wealth management expertise from Goldman Sachs Wealth Management Executive Board Julius Baer Chief Compliance Officer Victoria McLean
BRIEF published on 10/28/2025 at 07:05, 1 month 7 days ago Julius Baer to Establish New Branch in Lisbon Wealth Management European Expansion Julius Baer Lisbon Branch Client Proximity
PRESS RELEASE published on 10/28/2025 at 07:00, 1 month 7 days ago Julius Baer to set up new branch in Portugal Julius Baer expands presence in Europe with new branch in Lisbon, Portugal, strengthening wealth management network and client service for high-net-worth individuals Expansion Wealth Management Portugal Julius Baer Lisbon
BRIEF published on 07/22/2025 at 07:05, 4 months 13 days ago Julius Baer Reports 2025 Half-Year Results Amidst Challenges Net Profit Julius Baer Capitalisation 2025 Results Client Inflows
PRESS RELEASE published on 07/22/2025 at 07:00, 4 months 13 days ago Presentation of the 2025 half-year results for the Julius Baer Group Julius Baer Group presents strong 2025 half-year results with significant increase in net new money inflows, improved underlying net profit, and solid capitalization Half-year Results Julius Baer Capitalization Net New Money Underlying Net Profit
BRIEF published on 06/11/2025 at 17:50, 5 months 23 days ago Julius Baer Places EUR 500 Million Senior Unsecured Notes Euronext Dublin Institutional Investors Julius Baer Senior Unsecured Notes Debt Markets
PRESS RELEASE published on 06/11/2025 at 17:45, 5 months 23 days ago Julius Baer successfully places EUR 500 million senior unsecured notes Julius Baer Group Ltd. successfully places EUR 500 million senior unsecured notes through ELM B.V. in international debt markets, targeting European institutional investors Julius Baer Senior Unsecured Notes EUR 500 Million ELM B.V. European Institutional Investors
Published on 12/05/2025 at 02:35, 3 hours 25 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 55 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 30 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 9 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 35 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 45 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 49 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 15 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 59 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
